Lilly stock was up 4.8% at $969.14, putting it on pace for a record closing high, according to Dow Jones Market Data. The ...

() -MeiraGTx Holdings has signed a deal with Eli Lilly, potentially worth over $475 million,​ granting the pharma giant ...

Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including Plug Power (PLUG) ...

MeiraGTx (MGTX) shares added ~18% in the premarket on Monday after the genetic medicines company announced a broad strategic ...

Eli Lilly shares are rising Monday after Leerink Partners upgraded the stock to Outperform and raised its price target to ...

The announcement comes on the heels of a deal with the Trump administration to expand access to weight-loss drugs and reduce ...

MeiraGTx’s AAV-AIPL1 has already led to vision gains in blind children, as regulatory submissions for the gene therapy close ...

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.

Eli Lilly is inking a $100 million-plus biobucks deal with Insilico Medicine in hopes of using AI to discover new drugs. | Eli Lilly is inking a $100 million-plus biobucks deal with Insilico Medicine ...

In the preceding three months, 12 analysts have released ratings for Eli Lilly (NYSE: LLY ), presenting a wide array of perspectives from bullish to bearish. The following table summarizes their ...

A man who fainted in the Oval Office last week was a patient of a weight-loss drug company, according to reports.

Early results of Eli Lilly’s next generation of weight loss drugs appear to show promise, possibly leading to even faster ...